Jacob D. McFadden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jacob D. McFadden has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Timothy A. Masterson
Department of Urology, Indiana University School of Medicine, Indianapolis, IN
2 shared publicationsAndres Fajardo
Division of Vascular Surgery, Indiana University School of Medicine, Indianapolis, IN
1 shared publicationC. Cary
Department of Urology, Indiana University School of Medicine, Indianapolis, IN
1 shared publicationC. Schroeder
Department of Medical and Molecular Genetics, Indiana University Health, Indianapolis, IN
1 shared publicationClint Cary
Department of Urology, Indiana University School of Medicine, Indianapolis, IN
1 shared publication- Clint Cary
Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN
1 shared publication
Latest Publications
- 10 October 2024
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 43 (1) , 66.e1-66.e8
Short and long-term outcomes of arterial and caval replacement during postchemotherapy retroperitoneal lymph node dissection in metastatic testicular cancer
- 10 October 2024
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 43 (1) , 66.e1-66.e8
Short and long-term outcomes of arterial and caval replacement during postchemotherapy retroperitoneal lymph node dissection in metastatic testicular cancer
- 3 September 2024
- Published by Wiley in BJU International
- Vol. 134 (6) , 953-959
Contemporary short‐term peri‐operative outcomes of open primary retroperitoneal lymph node dissection
Objectives: To provide current peri‐operative outcomes and short‐term complication rates for open primary retroperitoneal lymph node dissection (RPLND), with analysis of risk factors for complications. Patients and Methods: Using the Indiana University Testicular Cancer database, we performed a retrospective analysis of all patients who underwent open primary RPLND over the study period (2018–2021). The primary outcomes of interest were the preoperative profile of patients undergoing surgery, complication rates, and identification of risk factors associated with complications. We used chi‐squared, Fisher's exact and unpaired t ‐tests in our analyses. Results: A total of 165 patients were identified. The median body mass index (BMI) was 28.6 kg/m 2 . Patients most often had clinical stage IIA (39%) or IIB testicular cancer (36%). The median estimated blood loss was 150 mL, with no transfusions required. Higher BMI was noted in patients that sustained any complication vs those with normal recovery (34.95 vs 28 kg/m 2 ; P = 0.0042). The median length of hospital stay was 3 days. The overall complication rate was low (8.48%), with two major postoperative complications, including one case of chylous ascites (0.6%), and no deaths in the 30‐day period. The study was limited by its retrospective design and short‐term follow‐up. Conclusions: We found that open primary RPLND has an acceptable morbidity profile, even among a predominantly overweight cohort. Low blood loss, short hospital stay, minimal chylous ascites risk, and rare major postoperative complications should be the benchmark for retroperitoneal lymph node dissection.
- 3 September 2024
- Published by Wiley in BJU International
- Vol. 134 (6) , 953-959
Contemporary short‐term peri‐operative outcomes of open primary retroperitoneal lymph node dissection
Objectives: To provide current peri‐operative outcomes and short‐term complication rates for open primary retroperitoneal lymph node dissection (RPLND), with analysis of risk factors for complications. Patients and Methods: Using the Indiana University Testicular Cancer database, we performed a retrospective analysis of all patients who underwent open primary RPLND over the study period (2018–2021). The primary outcomes of interest were the preoperative profile of patients undergoing surgery, complication rates, and identification of risk factors associated with complications. We used chi‐squared, Fisher's exact and unpaired t ‐tests in our analyses. Results: A total of 165 patients were identified. The median body mass index (BMI) was 28.6 kg/m 2 . Patients most often had clinical stage IIA (39%) or IIB testicular cancer (36%). The median estimated blood loss was 150 mL, with no transfusions required. Higher BMI was noted in patients that sustained any complication vs those with normal recovery (34.95 vs 28 kg/m 2 ; P = 0.0042). The median length of hospital stay was 3 days. The overall complication rate was low (8.48%), with two major postoperative complications, including one case of chylous ascites (0.6%), and no deaths in the 30‐day period. The study was limited by its retrospective design and short‐term follow‐up. Conclusions: We found that open primary RPLND has an acceptable morbidity profile, even among a predominantly overweight cohort. Low blood loss, short hospital stay, minimal chylous ascites risk, and rare major postoperative complications should be the benchmark for retroperitoneal lymph node dissection.
- 23 January 2024
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 42 (3) , 69.e11-69.e16
Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy
- 23 January 2024
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 42 (3) , 69.e11-69.e16
Impact of variant histology on upstaging and survival in patients with nonmuscle invasive bladder cancer undergoing radical cystectomy
- 23 January 2024
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 42 (3) , 72.e19-72.e25
Referral patterns and genetic testing outcomes in a contemporary hereditary renal cancer clinic
- 23 January 2024
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 42 (3) , 72.e19-72.e25
Referral patterns and genetic testing outcomes in a contemporary hereditary renal cancer clinic
- Open Access
- 5 August 2019
- Published by Hindawi Limited in Case Reports in Urology
- Vol. 2019, 2919686-5
Unusual Suspect: A Case Report of Tubulocystic Renal Cell Carcinoma with Features of Cystic Renal Oncocytoma.
Tubulocystic renal cell carcinoma is an uncommon subtype of renal cell carcinoma that was only recently acknowledged by the World Health Organization. There is a relatively small collection of literature dedicated to the features and clinical course of this lesion. Despite its rarity, this diagnosis should remain in the differential for all cystic renal masses. We present a case report of tubulocystic renal cell carcinoma (TC-RCC) with remarkable similarity to cystic renal oncocytoma, highlighting the diagnostic challenges associated with this unusual renal malignancy.
- 5 August 2019
- Published by Hindawi Limited in Case Reports in Urology
- Vol. 2019, 2919686-5
Open AccessUnusual Suspect: A Case Report of Tubulocystic Renal Cell Carcinoma with Features of Cystic Renal Oncocytoma.
Tubulocystic renal cell carcinoma is an uncommon subtype of renal cell carcinoma that was only recently acknowledged by the World Health Organization. There is a relatively small collection of literature dedicated to the features and clinical course of this lesion. Despite its rarity, this diagnosis should remain in the differential for all cystic renal masses. We present a case report of tubulocystic renal cell carcinoma (TC-RCC) with remarkable similarity to cystic renal oncocytoma, highlighting the diagnostic challenges associated with this unusual renal malignancy.
- Open Access
- 24 April 2018
- Published by Wiley in Case Reports in Urology
- Vol. 2018, 1-3
Page Kidney: An Unusual Complication of a Renal Transplant Biopsy
Page kidney, a rare phenomenon whereby external compression of renal parenchyma can induce hypertension, can be caused by subcapsular hematoma following renal transplant biopsy. Surgical intervention is often warranted to salvage the transplant kidney. This is a case report of a patient with acute T-cell-mediated rejection and no other risk factors for postprocedural bleeding that developed Page kidney. The patient had no signs or symptoms for >24 hours from the time of biopsy, underscoring the need for awareness of this rare but potentially catastrophic complication of renal transplant biopsies.
- 24 April 2018
- Published by Wiley in Case Reports in Urology
- Vol. 2018, 1-3
Open AccessPage Kidney: An Unusual Complication of a Renal Transplant Biopsy
Page kidney, a rare phenomenon whereby external compression of renal parenchyma can induce hypertension, can be caused by subcapsular hematoma following renal transplant biopsy. Surgical intervention is often warranted to salvage the transplant kidney. This is a case report of a patient with acute T-cell-mediated rejection and no other risk factors for postprocedural bleeding that developed Page kidney. The patient had no signs or symptoms for >24 hours from the time of biopsy, underscoring the need for awareness of this rare but potentially catastrophic complication of renal transplant biopsies.